Ionis Pharmaceuticals | IONS - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Agios Pharmaceuticals USD 113.6M 24.47M 2026-03
Alnylam Pharmaceuticals USD 1.71B 53.53M 2026-03
Arrowhead Research USD 201.64M 112.94M 2025-12
Astellas Pharma JPY 188.37B 8.51B 2025-03
BioCryst Pharmaceuticals USD 171.59M 164.32M 2026-03
BioMarin Pharmaceutical USD 2.22B 910.76M 2026-03
Celltrion KRW 49.87B 20.22B 2025-12
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
Esperion Therapeutics USD 156.16M 11.69M 2026-03
Exelixis USD 226.15M 256.34M 2026-03
Halozyme Therapeutics USD 309.75M 175.93M 2026-03
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
Kangmei Pharma CNY 1.23B 48.16M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Moderna USD 1.91B 687M 2026-03
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Neurocrine Biosciences USD 266.5M 446.5M 2026-03
Novartis USD 6.88B 4.56B 2026-03
Omeros USD 1.9M 2.36M 2025-06
OPKO Health USD 341.88M 27.22M 2026-03
Organigram Holdings CAD 4.29M 3.28M 2026-03
Pfizer USD 1.7B 561M 2026-03
Pharma Mar EUR 48.86M 31.05M 2026-03
PTC Therapeutics USD 833.99M 150.66M 2026-03
Qiagen NV USD 839M 516.58M 2025-12
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sarepta Therapeutics USD 464.45M 336.83M 2026-03
Sartorius EUR 573.8M 32.4M 2026-03
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Tilray USD 264.83M 43.16M 2025-06
Ultragenyx Pharmaceutical USD 175M 246M 2026-03
Vertex Pharmaceuticals USD 7.25B 638.6M 2026-03
Zealand Pharma A/S 4.58B 1.4B 2025-12
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03